ARS Pharmaceuticals Shares Halted To The Upside, Stock Now Down -54%
Portfolio Pulse from Benzinga Newsdesk
Shares of ARS Pharmaceuticals have been halted to the upside, with the stock now down by 54%.
September 20, 2023 | 1:45 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
ARS Pharmaceuticals' stock has been halted to the upside and is currently down by 54%.
The halt to the upside indicates that the stock's price has been stopped from increasing further. This, coupled with the fact that the stock is now down by 54%, suggests a negative impact on the company's stock price in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100